Application 065213

Type
ANDA
Sponsor
AKORN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONEBACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEOINTMENT;OPHTHALMIC400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GMNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0404-7195Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneHenry Schein Inc.ANDACurrent
0404-7195Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneHenry Schein Inc.ANDACurrent
0404-7195Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneHenry Schein Inc.ANDACurrent
13985-608Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneMWIANDACurrent
13985-608Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneMWIANDACurrent
13985-608Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneMWIANDACurrent
17478-719Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc, HydrocortisoneAkorn, Inc.ANDACurrent
17478-719Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc, HydrocortisoneAkornANDACurrent
17478-719Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and HydrocortisoneNeomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc, HydrocortisoneAkorn, Inc.ANDACurrent